Prediction of Duration of Mechanical Ventilation in ARDS

NCT ID: NCT05993377

Last Updated: 2024-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1303 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-14

Study Completion Date

2024-02-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are planning to perform a secondary analysis of an academic dataset of 1,303 patients with moderate-to-severe acute respiratory distress syndrome (ARDS) included in several published cohorts (NCT00736892, NCT022288949, NCT02836444, NCT03145974), aimed to characterize the best early scenario during the first three days of diagnosis to predict duration of mechanical ventilation in the intensive care unit (ICU) using supervised machine learning (ML) approaches.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The acute respiratory distress syndrome (ARDS) is an important cause of morbidity, mortality, and costs in intensive care units (ICUs) worldwide. Most ARDS patients require mechanical ventilation (MV). Few studies have investigated the prediction of MV duration of ARDS.

For model description and testing, the investigators will extract data from he first three ICU days after diagnosis of moderate-to-severe ARDS from patients included in the de-identified database, which includes 1,000 mechanically ventilated patients enrolled in several observational cohorts in Spain, coordinated by the principal investigator (JV), and funded by the Instituto de Salud Carlos III (ISCIII). The investigators will follow the TRIPOD guidelines and machine learning techniques will be implemented \[Random Forest (RF), eXtreme Gradient Boosting (XGBoost), and Logistic regression analysis) for the development and accuracy of prediction models. Disease progression will be tracked along those 3 ICU days to assess lung severity according to Berlin criteria. For external validation, the investigators will use 303 patients enrolled in a contemporary observational study (NCT03145974). The investigators will evaluate the accuracy of prediction models by calculation several statistics, such as sensitivity, specificity, positive predictive value, negative value for each model. The investigators will select the best early prediction model with data captured on the 1st, 2nd, or 3rd day.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Derivation and testing cohort

It will contain 1000 ARDS patients

Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .

Intervention Type OTHER

we will use robust machine learning approaches, such as Random Forest and XGBoost.

Confirmatory cohort

It will contain 303 patients (for external validation)

Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .

Intervention Type OTHER

we will use robust machine learning approaches, such as Random Forest and XGBoost.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .

we will use robust machine learning approaches, such as Random Forest and XGBoost.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Berlin criteria for moderate to severe acute respiratory distress syndrome

Exclusion Criteria

* Postoperative patients ventilated \<24h
* brain death patients
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unity Health Toronto

OTHER

Sponsor Role collaborator

Cardiff University

OTHER

Sponsor Role collaborator

Leiden University Medical Center

OTHER

Sponsor Role collaborator

Dr. Negrin University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jesus Villar

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jesús Villar

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario D. Negrin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitario Dr. Negrin

Las Palmas de Gran Canaria, Las Palmas, Spain

Site Status

Hospital Universitario Puerta de Hierro (ICU)

Majadahonda, Madrid, Spain

Site Status

Hospital Universitario NS de Candelaria

Santa Cruz de Tenerife, Tenerife, Spain

Site Status

Hospital NS del Prado

Talavera de la Reina, Toledo, Spain

Site Status

Hospital Universitario de A Coruña (ICU)

A Coruña, , Spain

Site Status

Complejo Hospitalario Universitario de Albacete (ICU)

Albacete, , Spain

Site Status

Complejo Hospitalario de Albacete

Albacete, , Spain

Site Status

Department of Anesthesia, Hospital Clinic

Barcelona, , Spain

Site Status

Hospital General de Ciudad Real (ICU)

Ciudad Real, , Spain

Site Status

Hospital Virgen de La Luz

Cuenca, , Spain

Site Status

Complejo Hospitalario Universitario de León

León, , Spain

Site Status

Hospital Universitario Ramón y Cajal (Anesthesia)

Madrid, , Spain

Site Status

Hospital Universitario La Paz (ICU)

Madrid, , Spain

Site Status

Hospital Fundación Jiménez Díaz

Madrid, , Spain

Site Status

Hospital Universitario Regional de Malaga Carlos Haya (ICU)

Málaga, , Spain

Site Status

Hospital Universitario Carlos Haya

Málaga, , Spain

Site Status

Hospital Universitario Virgen de Arrixaca (ICU)

Murcia, , Spain

Site Status

Hospital Universitario Río Hortega (ICU)

Valladolid, , Spain

Site Status

Hospital Virgen de la Concha (ICU)

Zamora, , Spain

Site Status

Cardiff University

Cardiff, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Villar J, Ambros A, Mosteiro F, Martinez D, Fernandez L, Ferrando C, Carriedo D, Soler JA, Parrilla D, Hernandez M, Andaluz-Ojeda D, Anon JM, Vidal A, Gonzalez-Higueras E, Martin-Rodriguez C, Diaz-Lamas AM, Blanco J, Belda J, Diaz-Dominguez FJ, Rico-Feijoo J, Martin-Delgado C, Romera MA, Gonzalez-Martin JM, Fernandez RL, Kacmarek RM; Spanish Initiative for Epidemiology, Stratification and Therapies of ARDS (SIESTA) Network. A Prognostic Enrichment Strategy for Selection of Patients With Acute Respiratory Distress Syndrome in Clinical Trials. Crit Care Med. 2019 Mar;47(3):377-385. doi: 10.1097/CCM.0000000000003624.

Reference Type RESULT
PMID: 30624279 (View on PubMed)

Figueroa-Casas JB, Dwivedi AK, Connery SM, Quansah R, Ellerbrook L, Galvis J. Predictive models of prolonged mechanical ventilation yield moderate accuracy. J Crit Care. 2015 Jun;30(3):502-5. doi: 10.1016/j.jcrc.2015.01.020. Epub 2015 Jan 30.

Reference Type RESULT
PMID: 25682346 (View on PubMed)

Villar J, Gonzalez-Martin JM, Fernandez C, Soler JA, Ambros A, Pita-Garcia L, Fernandez L, Ferrando C, Arocas B, Gonzalez-Vaquero M, Anon JM, Gonzalez-Higueras E, Parrilla D, Vidal A, Fernandez MM, Rodriguez-Suarez P, Fernandez RL, Gomez-Bentolila E, Burns KEA, Szakmany T, Steyerberg EW, The PredictION Of Duration Of mEchanical vEntilation In Ards Pioneer Network. Predicting the Length of Mechanical Ventilation in Acute Respiratory Disease Syndrome Using Machine Learning: The PIONEER Study. J Clin Med. 2024 Mar 21;13(6):1811. doi: 10.3390/jcm13061811.

Reference Type DERIVED
PMID: 38542033 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PIFIISC21-36

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.